glp-1 and glp-2 drugs medications linked to major drop in pancreatic, colorectal cancer risk https://www.medicalnewstoday.com/articles/weight-loss-drugs-glp-1 -slash-risk-4-types-cancer-50-or-more-study The GLP-1 revolution: What UAB

Since liraglutide is 97% homologous to natural GLP-1, the incidence of antibodies tested in the phase 3 clinical study was relatively low, with elevated antibody levels detected in less than 10% of individuals

Among the articles presented in this study, one of the major conclusions is that there is always a degree of uncertainty, especially among the patients currently using GLP-1 RAs

A Novel Glucose-Sensing Mechanism Contributing to Glucagon-Like Peptide-1 Secretion From the GLUTag Cell Line

A phase 2 trial assessing different doses of bimagrumab (up to 30 mg/kg) in combination with semaglutide as obesity treatment is ongoing (NCT05616013)

Harm to our natural GLP-1 pathway

Licensed indication : The same active ingredient may be marketed under different brand names for diabetes versus obesity (e.g., Ozempic vs Wegovy for semaglutide), with different pricing structures